Matthew Mimiaga

Matthew Mimiaga

Assistant Professor in the Department of Epidemiology

Department of Epidemiology

Department of Epidemiology

Kresge, Room 905

677 Huntington Avenue

Boston, Massachusetts 02115

mmimiaga@hsph.harvard.edu

 

Education

Post-Doctoral Fellowship, Harvard Medical School, 2008 ScD, Harvard School of Public Health, 2007 MPH, Boston University School of Public Health, 2003

 

Other Affiliations

Assistant Professor of Psychiatry, Harvard Medical School/Massachusetts General Hospital (Primary Appointment).

 

Research Program

My Research Team Currently Includes: 4 Post-Doctoral Fellows (Drs. Biello, Grelotti, Reisner, Robertson), 5 Graduate Students, 2 Epidemiology Project Managers, 1 Data Analyst, 1 Study Therapist, and 11 Research Assistants/Project Coordinators. In broad terms my research interests are in behavioral medicine, infectious disease and psychiatric epidemiology, and global health. My program of research involves designing and conducting intervention trials in HIV primary and secondary prevention, substance abuse treatment and prevention, and HIV medication adherence with a variety of populations, including sexual minority and other marginalized groups, substance users, adolescents, and individuals in resource limited countries. To date, I have authored or co-authored over 130 peer-reviewed, original research publications on these topics.

 

I am currently the Principal Investigator (PI) of six NIH funded R grants (two R01s, three R21s, one R34), a CDC research grant, and a grant funded by the Ragon Institute of MGH, MIT & Harvard working in these areas of research. Furthermore, I am currently a Co-I on four NIH R grants working in these areas of HIV prevention, and am a member of the protocol development team and Co-I for HPTN 063 (PI: Dr. Steven Safren) – a proposal to develop international prevention trials for HIV infected individuals in care settings in Zambia, Thailand, and Brazil. In addition to these three countries above, I am presently conducting global public health research in India, Vietnam, and South Africa, and collaborating on research projects with investigators at U Penn in Ukraine and Russia. Finally, I am the PI of an online study surveying all MSM members of one of the largest social/sexual networking Internet sites in all Latin American countries, Spain, and Portugal.

 

I am a standing member of the NIH Behavioral and Social Consequences of HIV/AIDS Study Section [BSCH], 2013-2019.

 

Current NIH/CDC Funded Research Studies For Which I Am PI: 

 

R34DA031028-01 – Mimiaga (PI) ** 09/01/2010-02/28/2015 ** NIDABehavioral Activation and HIV Risk Reduction for MSM with Crystal Meth Abuse. This study (“Project IMPACT”) aims to test a novel treatment for crystal methamphetamine dependence and sexual risk behavior in HIV uninfected MSM, incorporating behavioral activation training therapy with integrated HIV risk reduction counseling.

 

R01MH094323-01A1 - Mimiaga/Garofalo (MPI) ** 07/01/2011-06/30/2016 ** NIMHHIV Prevention Intervention for Young Transgender Women. This study is testing the efficacy of a uniquely targeted HIV risk reduction intervention (“Life Skills”) for sexually experienced young transgender women, ages 16 to 24, in a three-arm randomized controlled trial in two major U.S. cities: Boston and Chicago. Note: Dr. Sari L. Reisner (Post-Doctoral Fellow in ID Epi at HSPH) is a Co-I on this grant.

 

R21DA033720-01 – Mimiaga (PI) ** 09/30/2011-08/31/2014 ** NIDAInformation Technology for HIV Prevention Among Vulnerable Men in India. This study is to develop and pilot test an intervention that will use mobile phone technologies to deliver HIV prevention counseling to reduce sexual risk among male sex workers in Chennai and Mumbai, India. Note: Dr. Beena Thomas is the India/ICMR PI on this grant.

 

R21MH095535-01 – Mimiaga/Mitty (MPI) ** 08/09/2011-07/31/2014 ** NIMHUnderstanding PrEP Implementation among Club Drug Using MSM. This study has two phases: qualitative interviews (phase 1) and a larger epidemiological assessment (phase 2) among HIV uninfected MSM who report recent club drug use and concurrent sexual risk (in the last 3 months) to gain a better understanding of the facilitators and barriers to PrEP implementation.

 

R01HD075655-01A1 - Stephenson/Mimiaga/Garofalo (MPI) ** 04/10/2013-03/31/2018 ** NICHD - CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence. This study proposes to use CVCT combined with dyadic adherence counseling (“CVTCPlus”) to improve linkage to care, retention in care, ARV adherence and viral suppression among HIV-serodiscordant male-male couples in Atlanta, Boston, and Chicago.

 

R21DA035113-01A1 – Mimiaga/Biello (MPI) ** 05/10/2013-04/30/2015 ** NIDA - HIV Risk for MSM Sex Workers: A Social, Sexual and Drug Network Simulation Study. This is a longitudinal epidemiological study of MSM sex worker networks in Massachusetts to identify protective and risk factors that affect HIV transmission dynamics. Longitudinal data will enhance our understanding of how contemporary social, sexual, and drug abuse network characteristics contribute to increased HIV and STI spread among MSM sex workers. The information gained will be used to develop a simulation model to examine which prevention modality (e.g., network-based, conditional cash transfer, PrEP, etc) would impact decreased HIV incidence most successfully.

 

200-2012-53307 – Mimiaga/Ojikutu (MPI) ** 10/01/2012-12/31/2014 ** CDC Testing Brief Messages for Black and Latino MSM: Emerging HIV Prevention Information. The aims of this study are to understand the differing effects of biomedical and behavioral prevention messaging among Black and Latino MSM who are at risk for HIV infection. This project will help advance CDC’s high impact prevention efforts to achieve the goals of the National HIV/AIDS Strategy.

 

 

Completed NIH Funded Research Studies For Which I Was PI: 

 

2P30AI060354-06 – Mimiaga (PI) ** 06/01/2010-12/31/2012 ** NIAID (Harvard CFAR)Improving Antiretroviral Medication Adherence Among HIV Infected Youth. This study was to develop (through extensive qualitative methods) and pilot test in an RCT design a theoretically-driven intervention curriculum (“Positive STEPS”) grounded in the social-cognitive and contextual realities of HIV infected adolescents (aged 13-24) to improve medication adherence.

 

2P30AI060354-06 - Mimiaga/Mitty (MPI) ** 06/01/2010-12/31/2012 ** NIAID (Harvard CFAR)Sustaining Effects of CM on Stimulant Use in HIV Infected Persons. The aims of this study were to develop and implement through an open phase pilot a combined contingency management (CM) and behavioral activation training therapy intervention (“Project REWARD”) aimed at HIV infected individuals who were engaged in HIV care and dependent on stimulants (cocaine, crack or crystal methamphetamine).

 

UL1RR025758-02 – Colby/Mimiaga (MPI) ** 02/01/2010-10/31/2011 ** NIH (Harvard Catalyst) Sexual Health Needs of Male Sex Workers in Ho Chi Minh City, Vietnam. The aim was to conduct formative research to better understand risk and protective factors for HIV/STI transmission among MSW in Ho Chi Minh City. These findings were used to develop a specific intervention designed to decrease HIV/STI risk behavior among MSW in Vietnam, which we are currently pilot testing among a sample of 100 MSW.

 

R03DA023393-01 – Mimiaga (PI) ** 02/01/2008-01/31/2011 ** NIDA - Behavioral Activation and HIV Risk Reduction for MSM with Crystal Meth Abuse. The aim of this project was to develop and openly pilot test a behavioral intervention that integrates behavioral activation and HIV risk reduction counseling for MSM with crystal meth abuse. This study serves as the major preliminary data supporting my current NIDA funded R34.

 

Courses Taught

EPI 220 – Psych Diagnosis; Clinic and Community Populations (Spring)